Peripheral T cell lymphomas (PTCLs) are a heterogeneous group of orphan neoplasms.
Despite the introduction of anthracycline-based chemotherapy protocols, with or without …

Diffuse large B-cell lymphoma (DLBCL) is a clinically heterogeneous lymphoid malignancy
and the most common subtype of non-Hodgkin's lymphoma in adults, with one of the highest …

Background Patients with relapsed or refractory diffuse large B-cell lymphoma who are
ineligible for autologous stem-cell transplantation have poor outcomes and few treatment …

Abstract Purpose: Randomized, multicenter, open-label, phase 2/3 trial investigating
lenalidomide versus investigator's choice (IC) in relapsed/refractory diffuse large B-cell …

To interrogate signaling pathways activated in mantle cell lymphoma (MCL) in vivo, we
contrasted gene expression profiles of 55 tumor samples isolated from blood and lymph …

The combination of pomalidomide (POM) and dexamethasone (DEX) was evaluated for
relapsed/refractory primary central nervous system lymphoma (PCNSL) and primary …

Cutaneous lymphomas (CL) are categorized as extranodal non-Hodgkin lymphomas,
constituting the second most common form in this group (MALT lymphomas of the stomach …

Abstract The Ten Eleven Translocation (TET) enzymes have been found to be mutated in
both diffuse large B-cell (DLBCL) and peripheral T-cell (PTCL) lymphomas resulting in DNA …

Several studies have identified mutations in the MYD88L265P gene as a key driver mutation
in several B-cell lymphomas. B-cell lymphomas that harbor the MYD88L265P mutation form …

Background Advances in understanding of cancer biology, genomics, epigenomics, and
immunology have resulted in development of several therapeutic options that expand …